Antiretroviral therapy of acute HIV-infection

Abstract


Aim. To study efficacy of a short course of highly active antiretroviral therapy (HAART). Material and methods. Acute HIV infection was verified in 16 infected subjects basing either on seroconversion (by immunoblotting) or a documented negative result 6-12 months before registration of a positive result for HIV antibodies.
Results. HAART was given to 12 patients (combivir+nevirapin). The number of CD+ lymphocytes (by median) 1 month after the treatment increased by 185 cells/mcl, 3 months after the treatment - by 215 cells/mcl. After 1-month therapy viral load (median) diminished by 2,02 logl0 copy/ml, after 3 months - by 2,31 logw copy/ml. 71% patients had HIV RNA under 400 copy/ml. Untreated patients showed changes neither in CD4+lymphocytes number nor in viral load. The study continues. Conclusion. HAART is used at the stage of acute infection in the presence of psychic trauma provoked by establishment of HIV-infection diagnosis. Therefore, it is necessary to consult the patients for preparing them for treatment and to maintain compliance.

References

  1. Hoffmann С., Komps В. S. HIV medicine 2003. Paris: Flying Publisher; 2003.
  2. Кравченко А. В., Юрин О. Г., Буравцова Е. В. и др. Клинические проявления ВИЧ-инфекции в периоде сероконверсии. Тер. арх. 1995; 67 (11): 24-27.
  3. Кравченко А. В., Юрин О. Г., Серебровская Л. В. и др. Прогностическое значение клинических проявлений ВИЧ-инфекции в периоде сероконверсии. Тер. арх. 1994; 66 (11): 42-44.
  4. Filder S. J., Brady M. D., Oxenius A. et al. Immunological and virological effects of short course antiretroviral therapy in primary HIV infection. In: XIV International AIDS conference. Barcelona; 2002. abstr. TuOrB1185.
  5. Brady M., Filder S., Dunstan S. et al. Short course antiretroviral therapy in primary HIV infection does not induce significant drug resistant mutation. In: 6-th International congress on drug therapy in HIV infection. Glasgow; 2002. abstr. P212.
  6. Walker S. et al. Prompt HAART after HIV seroconversion boots short-term success. J. Acquir. Immune Defic. Syndr. 2003; 32: 303-310.
  7. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. http://www.liivatis.org (accessed 14 July 2003).
  8. Беляева В. В., Покровский В. В., Кравченко А. В. Консультирование при ВИЧ-инфекции: Пособие для врачей различных специальностей. М.; 2003.
  9. ВИЧ-инфекция: клиника, диагностика и лечение / Покровский В. В., Ермак Т. Н., Беляева В. В., Юрин О. Г.; Под общ. ред. В. В. Покровского. 2-е изд. М.: ГЕОТАРМЕД; 2003.

Statistics

Views

Abstract - 95

Cited-By


Article Metrics

Metrics Loading ...

Refbacks

  • There are currently no refbacks.

Copyright (c) 2004 Kravchenko A.V., Miroshnichenko A.V., Belyaeva V.V., Serebrovskaya L.V., Bogoslovskaya E.V., Sitdykova Y.R.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Novoslobodskaya str 31c4., Moscow, 127005, Russian Federation

Managing Editor:

 

© 2018 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies